Revolutionary drug for schizophrenia wins US approval

Elie Dolgin • September 26, 2024

The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.

Read at Nature.

‘Connectoids’ use microfluid channels to recapitulate and study neural connections.
By Elie Dolgin May 14, 2025
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Picture of scientist handling mRNA, Robert F. Kennedy Jr. and vaccine protesters.
By Elie Dolgin May 9, 2025
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.